A prospective, multi center, single blind, randomized controlled study evaluating “AyurCoro3” as an adjuvant in the treatment of mild to moderate COVID-19 patients
… [1] Since April 2021, there has been a second wave of COVID-19 infections in Indian sub… Mild-to-moderate infections were characterized by the presence of symptoms of mild pneumonia…..... Read More